The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract
Open accessAbstract
PURPOSE: Evaluate the safety and effectiveness of an ab interno implanted (iStent inject) Trabecular Micro-Bypass System (Glaukos Corporation, San Clemente, CA) in combination with cataract surgery in subjects with mild to moderate primary open-angle glaucoma (POAG). DESIGN: Prospective, randomized, single-masked, concurrently controlled, multicenter clinical trial. PARTICIPANTS: Eyes with mild to moderate POAG and preoperative intraocular pressure (IOP) ≤24 mmHg on 1 to 3 medications, unmedicated diurnal IOP (DIOP) 21 to 36 mmHg, and cataract requiring surgery. METHODS: After uncomplicated cataract surgery, eyes were randomized 3:1 intraoperatively to ab interno implantation of iStent inject (Model G2-M-IS; treatment group, n = 387) or no stent implantation (control group, n = 118). Subjects were followed through 2 years postoperatively. Annual washout of ocular hypotensive medication was performed. MAIN OUTCOME MEASURES: Effectiveness end points were ≥20% reduction from baseline in month 24 unmedicated DIOP and change in unmedicated month 24 DIOP from baseline. Safety measures included best spectacle-corrected visual acuity (BSCVA), slit-lamp and fundus examinations, gonioscopy, pachymetry, specular microscopy, visual fields, complications, and adverse events. RESULTS: The groups were well balanced preoperatively, including medicated IOP (17.5 mmHg in both groups) and unmedicated DIOP (24.8±3.3 mmHg vs. 24.5±3.1 mmHg in the treatment and control groups, respectively, P = 0.33). At 24 months, 75.8% of treatment eyes versus 61.9% of control eyes experienced ≥20% reduction from baseline in unmedicated DIOP (P = 0.005), and mean reduction in unmedicated DIOP from baseline was greater in treatment eyes (7.0±4.0 mmHg) than in control eyes (5.4±3.7 mmHg; P < 0.001). Of the responders, 84% of treatment eyes and 67% of control eyes were not receiving ocular hypotensive medication at 23 months. Furthermore, 63.2% of treatment eyes versus 50.0% of control eyes had month 24 medication-free DIOP ≤18 mmHg (difference 13.2%; 95% confidence interval, 2.9-23.4). The overall safety profile of the treatment group was favorable and similar to that in the control group throughout the 2-year follow-up. CONCLUSIONS: Clinically and statistically greater reductions in IOP without medication were achieved after iStent inject implantation with cataract surgery versus cataract surgery alone, with excellent safety through 2 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
Tham, Y.-C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C.-Y. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.013 · Cited by 7,159
Heijl, A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1268 · Cited by 3,320
Factors for Glaucoma Progression and the Effect of Treatment: The Early Manifest Glaucoma Trial
Leske, M. C. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.1.48 · Cited by 2,030
The Ocular Hypertension Treatment Study: Design and Baseline Description of the Participants
Gordon, M. O. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.5.573 · Cited by 441
Craven, R. E., Katz, J. L., Wells, J. M., & Giamporcaro, J. E. (2012) · Journal of Cataract and Refractive Surgery · doi:10.1016/j.jcrs.2012.03.025 · Cited by 344
Self-citation(2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.09.025 · Cited by 309
Adherence with Topical Glaucoma Medication Monitored Electronically
Okeke, C. O., Quigley, H. A., Jampel, H. D., Ying, G.-S., Plyler, R. J., Jiang, Y., & Friedman, D. S. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.09.004 · Cited by 305
Self-citationBoland, M. V., Ervin, A.-M., Friedman, D. S., Jampel, H. D., Hawkins, B. S., Vollenweider, D., Chelladurai, Y., Ward, D., Suarez-Cuervo, C., & Robinson, K. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-4-201302190-00008 · Cited by 303
Friedman, D. S., Quigley, H. A., Gelb, L., Tan, J., Margolis, J., Shah, S. N., Kim, E. E., Zimmerman, T., & Hahn, S. R. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0290 · Cited by 281
Cited by
Primary Open-Angle Glaucoma Preferred Practice Pattern®
Gedde, S. J., Vinod, K., Wright, M. M., Muir, K. W., Lind, J. T., Chen, P. P., Li, T., & Mansberger, S. L. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.10.022 · Cited by 474
Metadata
- Authors
- Samuelson, T. W., Sarkisian, S. R., Lubeck, D. M., Stiles, M. C., Duh, Y.-J., Romo, E. A., Giamporcaro, J. E., Hornbeak, D. M., Katz, L. J., Bartlett, W., Buznego, C., Johnson, S., D'Ambrosio, F. A., Dehning, D., DuBiner, H., Goyal, R., Hughes, B., Marquis, R. E., Noecker, R., Tauber, S., Perez, B. R., Roel, L., Sarkisian, S., Silverstein, S., Day, S., Solomon, K., Tyson, F., Vold, S., Samuelson, T., Simmons, S., Stiles, M., Nguyen, Q. H., Bashford, K. P., Flowers, B., Flynn, W. J., Gira, J., Okeke, C., Reiss, G. R., Tyson, S. L., Parkhurst, G., Linn, J., Lubeck, D., Solomon, J., Singh, I. P., Johnson, R. D., Lin, C., Kim, J. W., Crane, C. J., & Cotter, F.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 126
- Issue
- 6
- Pages
- 811-821
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2921397391
- Cited by
- 307
- References
- 20
- FWCI
- 30.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract. https://app.cochat.ai/papers/10.1016/j.ophtha.2019.03.006
- The paper
- Samuelson, T. W., Sarkisian, S. R., Lubeck, D. M., Stiles, M. C., Duh, Y.-J., Romo, E. A., Giamporcaro, J. E., Hornbeak, D. M., Katz, L. J., Bartlett, W., Buznego, C., Johnson, S., D'Ambrosio, F. A., Dehning, D., DuBiner, H., Goyal, R., Hughes, B., Marquis, R. E., Noecker, R., . . . Cotter, F. (2019). Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract. Ophthalmology. https://doi.org/10.1016/j.ophtha.2019.03.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.